secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2022-11-10T23:59:59+00:00
Accession:  0001493152-22-031348
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lixte Biotechnology promotes Forman to COO with $200k salary, grants options at $2.00 and warrants at $0.50
--------------------------------------------------------------------------------

- Promoted Eric Forman from CAO to VP and COO; salary increased from $175k to $200k.
- Granted options to purchase 200k shares each to Kovach, Forman, Miser, and Weingarten at $2.00/share; market price $0.5025.
- Amended bylaws to reduce stockholder meeting quorum from majority to 33-1/3% of voting power.
- Issued warrants to BioPharmaWorks LLC for 100k shares at $0.5025/share, fully vested, 5-year term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315222031348/0001493152-22-031348-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315222031348/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-031348

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer